{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:28:08Z","timestamp":1790483288191,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"HNFP"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","ijdp.org","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Drug Policy"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.drugpo.2016.11.006","type":"journal-article","created":{"date-parts":[[2016,12,13]],"date-time":"2016-12-13T20:02:14Z","timestamp":1481659334000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["HCV prevalence and risk behaviours among injectors of new psychoactive substances in a risk environment in Hungary\u2014An expanding public health burden"],"prefix":"10.1016","volume":"41","author":[{"given":"Anna","family":"Tarj\u00e1n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1ria","family":"Dud\u00e1s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Wiessing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gergely","family":"Horv\u00e1th","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erzs\u00e9bet","family":"Rusvai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e1lint","family":"Tres\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1gnes","family":"Csoh\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugpo.2016.11.006_bib0005","series-title":"HIV\/AIDS among injecting drug users in Romania. Report of a recent outbreak and initial response policies","author":"Botescu","year":"2012"},{"issue":"12","key":"10.1016\/j.drugpo.2016.11.006_bib0010","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.drugpo.2015.07.013","article-title":"Chemsex and harm reduction need among gay men in South London","volume":"26","author":"Bourne","year":"2015","journal-title":"International Journal of Drug Policy"},{"issue":"12","key":"10.1016\/j.drugpo.2016.11.006_bib0015","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/jvh.12008","article-title":"Accessing Hepatitis C patients who are difficult to reach: It is time to overcome barriers","volume":"19","author":"Bruggmann","year":"2012","journal-title":"Journal of Viral Hepatitis"},{"issue":"Suppl. 1","key":"10.1016\/j.drugpo.2016.11.006_bib0020","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/j.drugpo.2014.08.014","article-title":"Prevention, treatment and care of hepatitis C virus infection among people who inject drugs","volume":"26","author":"Bruggmann","year":"2015","journal-title":"International Journal of Drug Policy"},{"issue":"4","key":"10.1016\/j.drugpo.2016.11.006_bib0025","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1080\/10826080802544349","article-title":"Access to sterile injecting equipment is more important than awareness of HCV status for injection risk behaviors among drug users","volume":"44","author":"Cox","year":"2009","journal-title":"Substance Use & Misuse"},{"issue":"6","key":"10.1016\/j.drugpo.2016.11.006_bib0030","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1177\/0269881113480987","article-title":"Transition to injecting 3,4-methylene-dioxy-pyrovalerone (MDPV) among needle exchange program participants in Hungary","volume":"27","author":"Csak","year":"2013","journal-title":"Journal of Psychopharmacology"},{"issue":"9737","key":"10.1016\/j.drugpo.2016.11.006_bib0035","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0140-6736(10)60742-8","article-title":"Prevention of HIV infection for people who inject drugs: Why individual, structural, and combination approaches are needed","volume":"376","author":"Degenhardt","year":"2010","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.drugpo.2016.11.006_bib0040","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jhep.2015.03.025","article-title":"EASL recommendations on treatment of Hepatitis C 2015","volume":"63","year":"2015","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.drugpo.2016.11.006_bib0045","series-title":"Hepatitis C surveillance in Europe\u20142013","author":"ECDC","year":"2015"},{"key":"10.1016\/j.drugpo.2016.11.006_bib0050","series-title":"Prevention and control of infectious diseases among people who inject drugs","author":"ECDC","year":"2011"},{"key":"10.1016\/j.drugpo.2016.11.006_bib0055","series-title":"Hepatitis C and injecting drug use: Impact, costs and policy options","author":"EMCDDA","year":"2004"},{"key":"10.1016\/j.drugpo.2016.11.006_bib0060","series-title":"Protocol for the implementation of the EMCDDA key indicator drug related infectious diseases (DRID), draft version 6 October 2006","author":"EMCDDA","year":"2006"},{"key":"10.1016\/j.drugpo.2016.11.006_bib0065","series-title":"Standard stable 9","author":"EMCDDA","year":"2013"},{"key":"10.1016\/j.drugpo.2016.11.006_bib0070","series-title":"Drug-related infectious diseases in Europe: Update from the EMCDDA expert network","author":"EMCDDA","year":"2015"},{"key":"10.1016\/j.drugpo.2016.11.006_bib0075","series-title":"Perspectives on drugs","article-title":"Injection of synthetic cathinones","author":"EMCDDA","year":"2015"},{"key":"10.1016\/j.drugpo.2016.11.006_bib0080","series-title":"Joint EMCDDA and ECDC rapid risk assessment: HIV in injecting drug users in the EU\/EEA, following a reported increase of cases in Greece and Romania (Publication no. 10.2810\/50417)","author":"EMCDDA","year":"2012"},{"key":"10.1016\/j.drugpo.2016.11.006_bib0085","series-title":"New drugs in Europe, 2012. EMCDDA-Europol 2012 Annual Report on the implementation of Council Decision 2005\/387\/JHA","author":"EMCDDA","year":"2013"},{"key":"10.1016\/j.drugpo.2016.11.006_bib0090","series-title":"HIV outbreak among injecting drug users in Greece. An updated brief report for the EMCDDA on the recent outbreak of HIV infections among drug injectors in Greece","author":"Fotiou","year":"2012"},{"issue":"3","key":"10.1016\/j.drugpo.2016.11.006_bib0095","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.drugpo.2008.10.006","article-title":"Theorizing Big Events as a potential risk environment for drug use, drug-related harm and HIV epidemic outbreaks","volume":"20","author":"Friedman","year":"2009","journal-title":"International Journal of Drug Policy"},{"issue":"4","key":"10.1016\/j.drugpo.2016.11.006_bib0100","first-page":"459","article-title":"Barriers to antiviral treatment in hepatitis C infected intravenous drug users","volume":"12","author":"Gazdag","year":"2010","journal-title":"Neuropsychopharmacologia Hungarica"},{"issue":"40","key":"10.1016\/j.drugpo.2016.11.006_bib0105","article-title":"Injection of new psychoactive substance snow blow associated with recently acquired HIV infections among homeless people who inject drugs in Dublin, Ireland, 2015","volume":"20","author":"Giese","year":"2015","journal-title":"Euro Surveillance"},{"issue":"1","key":"10.1016\/j.drugpo.2016.11.006_bib0110","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12889-016-2842-2","article-title":"A needle in the haystack\u2014The dire straits of needle exchange in Hungary","volume":"16","author":"Gyarmathy","year":"2016","journal-title":"BMC Public Health"},{"issue":"3","key":"10.1016\/j.drugpo.2016.11.006_bib0115","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.drugalcdep.2008.10.014","article-title":"The association of syringe type and syringe cleaning with HCV infection among IDUs in Budapest, Hungary","volume":"100","author":"Gyarmathy","year":"2009","journal-title":"Drug and Alcohol Dependence"},{"issue":"4","key":"10.1016\/j.drugpo.2016.11.006_bib0120","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1086\/600304","article-title":"Hepatitis C treatment for injection drug users: A review of the available evidence","volume":"49","author":"Hellard","year":"2009","journal-title":"Clinical Infectious Diseases"},{"issue":"7","key":"10.1016\/j.drugpo.2016.11.006_bib0125","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ajic.2006.08.002","article-title":"Tattooing in prisons\u2014Not such a pretty picture","volume":"35","author":"Hellard","year":"2007","journal-title":"American Journal of Infection Control"},{"key":"10.1016\/j.drugpo.2016.11.006_bib0130","series-title":"2010 National Report to the EMCDDA","author":"HNFP","year":"2010"},{"issue":"19","key":"10.1016\/j.drugpo.2016.11.006_bib0135","article-title":"Is the recent emergence of mephedrone injecting in the United Kingdom associated with elevated risk behaviours and blood borne virus infection?","volume":"21","author":"Hope","year":"2016","journal-title":"Euro Surveillance"},{"key":"10.1016\/j.drugpo.2016.11.006_bib0140","series-title":"Drugs (report)","author":"Horv\u00e1th","year":"2015"},{"key":"10.1016\/j.drugpo.2016.11.006_bib0145","series-title":"Drugs (report)","author":"Horv\u00e1th","year":"2016"},{"key":"10.1016\/j.drugpo.2016.11.006_bib0150","series-title":"Harms and harm reduction","author":"Horv\u00e1th","year":"2015"},{"issue":"1\u20132","key":"10.1016\/j.drugpo.2016.11.006_bib0155","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.drugalcdep.2012.05.008","article-title":"High-risk drug-use practices among a large sample of Australian prisoners","volume":"126","author":"Kinner","year":"2012","journal-title":"Drug and Alcohol Dependence"},{"issue":"9266","key":"10.1016\/j.drugpo.2016.11.006_bib0160","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/S0140-6736(00)04562-1","article-title":"Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: Risk-factor analysis","volume":"357","author":"Kral","year":"2001","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.drugpo.2016.11.006_bib0165","doi-asserted-by":"crossref","first-page":"986","DOI":"10.5812\/kowsar.1735143X.4216","article-title":"Intravenous drug users can achieve a high sustained virological response rate: Experience from Croatian Reference Center for viral hepatitis","volume":"11","author":"Kurelac","year":"2011","journal-title":"Hepatitis Monthly"},{"issue":"Suppl. 6","key":"10.1016\/j.drugpo.2016.11.006_bib0170","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1186\/1471-2334-14-S6-S16","article-title":"A systematic review of Hepatitis C virus treatment uptake among people who inject drugs in the European Region","volume":"14","author":"Lazarus","year":"2014","journal-title":"BMC Infectious Diseases"},{"issue":"6","key":"10.1016\/j.drugpo.2016.11.006_bib0175","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.jhep.2010.08.029","article-title":"Can antiviral therapy for hepatitis C reduce the prevalence of HCV among injecting drug user populations? A modeling analysis of its prevention utility","volume":"54","author":"Martin","year":"2011","journal-title":"Journal of Hepatology"},{"issue":"1","key":"10.1016\/j.drugpo.2016.11.006_bib0180","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/hep.24656","article-title":"Cost-effectiveness of hepatitis C virus antiviral treatment for injection drug user populations","volume":"55","author":"Martin","year":"2012","journal-title":"Hepatology"},{"issue":"9719","key":"10.1016\/j.drugpo.2016.11.006_bib0185","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/S0140-6736(10)60232-2","article-title":"HIV prevention, treatment, and care services for people who inject drugs: A systematic review of global, regional, and national coverage","volume":"375","author":"Mathers","year":"2010","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.drugpo.2016.11.006_bib0190","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/add.13056","article-title":"The drug situation in Europe: An overview of data available on illicit drugs and new psychoactive substances from European monitoring in 2015","volume":"111","author":"Mounteney","year":"2016","journal-title":"Addiction"},{"key":"10.1016\/j.drugpo.2016.11.006_bib0195","series-title":"A Hepatitis C v\u00edrus okozta kr\u00f3nikus m\u00e1jgyullad\u00e1s diagnosztik\u00e1ja \u00e9s ter\u00e1pi\u00e1j\u00e1nak finansz\u00edroz\u00e1si protokollja","author":"OEP","year":"2013"},{"issue":"3","key":"10.1016\/j.drugpo.2016.11.006_bib0200","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S1665-2681(19)31271-2","article-title":"HCV antiviral therapy in injection drug users: Difficult to treat or easy to cure?","volume":"14","author":"Persico","year":"2015","journal-title":"Annals of Hepatology"},{"key":"10.1016\/j.drugpo.2016.11.006_bib0205","series-title":"Treatment (report)","author":"P\u00e9terfi","year":"2015"},{"issue":"7\u20138","key":"10.1016\/j.drugpo.2016.11.006_bib0210","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/dta.1625","article-title":"Changes in patterns of injecting drug use in Hungary: A shift to synthetic cathinones","volume":"6","author":"Peterfi","year":"2014","journal-title":"Drug Testing and Analysis"},{"issue":"1","key":"10.1016\/j.drugpo.2016.11.006_bib0215","first-page":"29","article-title":"The phenomenon of drug change in the interviews with injecting drug users","volume":"27","author":"Racz","year":"2012","journal-title":"Psychiatria Hungarica"},{"key":"10.1016\/j.drugpo.2016.11.006_bib0220","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.drugalcdep.2015.10.034","article-title":"Veni, vidi, vici: The appearance and dominance of new psychoactive substances among new participants at the largest needle exchange program in Hungary between 2006 and 2014","volume":"158","author":"Racz","year":"2016","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.drugpo.2016.11.006_bib0225","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.drugpo.2015.05.026","article-title":"New cases of HIV among people who inject drugs in Hungary: False alarm or early warning?","volume":"27","author":"Racz","year":"2016","journal-title":"International Journal of Drug Policy"},{"issue":"3","key":"10.1016\/j.drugpo.2016.11.006_bib0230","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.drugpo.2008.10.003","article-title":"Risk environments and drug harms: A social science for harm reduction approach","volume":"20","author":"Rhodes","year":"2009","journal-title":"International Journal of Drug Policy"},{"issue":"1","key":"10.1016\/j.drugpo.2016.11.006_bib0235","doi-asserted-by":"crossref","first-page":"196","DOI":"10.2105\/AJPH.2013.301656","article-title":"Homelessness and other risk factors for HIV infection in the current outbreak among injection drug users in Athens, Greece","volume":"105","author":"Sypsa","year":"2015","journal-title":"American Journal of Public Health"},{"issue":"7","key":"10.1016\/j.drugpo.2016.11.006_bib0240","doi-asserted-by":"crossref","first-page":"848","DOI":"10.3109\/10826084.2015.978672","article-title":"Emerging risks due to new injecting patterns in hungary during austerity times","volume":"50","author":"Tarjan","year":"2015","journal-title":"Substance Use & Misuse"},{"issue":"1","key":"10.1016\/j.drugpo.2016.11.006_bib0245","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s11524-011-9626-x","article-title":"Prevalence and correlates of HCV, HVB, and HIV infection among prison inmates and staff, Hungary","volume":"89","author":"Treso","year":"2012","journal-title":"Journal of Urban Health"},{"issue":"11","key":"10.1016\/j.drugpo.2016.11.006_bib0250","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1111\/j.1360-0443.2011.03515.x","article-title":"The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: Pooling of UK evidence","volume":"106","author":"Turner","year":"2011","journal-title":"Addiction"},{"key":"10.1016\/j.drugpo.2016.11.006_bib0255","series-title":"World drug report 2013","author":"UNODC","year":"2013"},{"key":"10.1016\/j.drugpo.2016.11.006_bib0260","series-title":"Injecting use of synthetic drugs","author":"UNODC","year":"2016"},{"issue":"3","key":"10.1016\/j.drugpo.2016.11.006_bib0265","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.drugpo.2012.01.008","article-title":"A costly turn on: Patterns of use and perceived consequences of mephedrone based head shop products amongst Irish injectors","volume":"23","author":"Van Hout","year":"2012","journal-title":"International Journal of Drug Policy"},{"issue":"2","key":"10.1016\/j.drugpo.2016.11.006_bib0270","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1360-0443.2009.02759.x","article-title":"Can hepatitis C virus prevalence be used as a measure of injection-related human immunodeficiency virus risk in populations of injecting drug users? An ecological analysis","volume":"105","author":"Vickerman","year":"2010","journal-title":"Addiction"},{"issue":"11","key":"10.1016\/j.drugpo.2016.11.006_bib0275","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1111\/j.1360-0443.2012.03932.x","article-title":"Can needle and syringe programmes and opiate substitution therapy achieve substantial reductions in hepatitis C virus prevalence? Model projections for different epidemic settings","volume":"107","author":"Vickerman","year":"2012","journal-title":"Addiction"},{"issue":"1\u20132","key":"10.1016\/j.drugpo.2016.11.006_bib0280","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.drugalcdep.2013.01.020","article-title":"Is the HCV-HIV co-infection prevalence amongst injecting drug users a marker for the level of sexual and injection related HIV transmission?","volume":"132","author":"Vickerman","year":"2013","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.drugpo.2016.11.006_bib0285","series-title":"Technical guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users","author":"WHO","year":"2013"},{"key":"10.1016\/j.drugpo.2016.11.006_bib0290","series-title":"New EMCDDA toolkit for monitoring infectious diseases","author":"Wiessing","year":"2014"},{"issue":"7","key":"10.1016\/j.drugpo.2016.11.006_bib0295","doi-asserted-by":"crossref","first-page":"e103345","DOI":"10.1371\/journal.pone.0103345","article-title":"Hepatitis C virus infection epidemiology among people who inject drugs in Europe: A systematic review of data for scaling up treatment and prevention","volume":"9","author":"Wiessing","year":"2014","journal-title":"PLoS One"},{"issue":"48","key":"10.1016\/j.drugpo.2016.11.006_bib0300","article-title":"Trends in HIV and hepatitis C virus infections among injecting drug users in Europe, 2005 to 2010","volume":"16","author":"Wiessing","year":"2011","journal-title":"Euro Surveillance"}],"container-title":["International Journal of Drug Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395916303413?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395916303413?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T09:50:01Z","timestamp":1568627401000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955395916303413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":60,"alternative-id":["S0955395916303413"],"URL":"https:\/\/doi.org\/10.1016\/j.drugpo.2016.11.006","relation":{},"ISSN":["0955-3959"],"issn-type":[{"value":"0955-3959","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HCV prevalence and risk behaviours among injectors of new psychoactive substances in a risk environment in Hungary\u2014An expanding public health burden","name":"articletitle","label":"Article Title"},{"value":"International Journal of Drug Policy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugpo.2016.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}